Jiangsu Hengrui Medicine Co., Ltd. (SHA: 600276)

Jiangsu Hengrui Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	22,132	20,746	15,111	13,631	10,805	5,044
Trading Asset Securities	773.72	99.05	2,760	5,090	5,628	8,520
Cash & Short-Term Investments	22,905	20,845	17,871	18,721	16,433	13,563
Cash Growth	30.03%	16.64%	-4.54%	13.93%	21.15%	248.70%
Accounts Receivable	6,792	6,135	8,341	6,884	8,176	5,435
Other Receivables	130.65	438.25	562.18	658	651.15	982.05
Receivables	6,923	6,573	8,904	7,542	8,827	6,417
Inventory	2,531	2,314	2,451	2,403	1,778	1,607
Prepaid Expenses	-	226.07	507.2	431.57	410.18	86.07
Other Current Assets	2,098	1,329	1,201	1,090	602.25	638.13
Total Current Assets	34,457	31,287	30,934	30,188	28,050	22,311
Property, Plant & Equipment	6,689	6,629	6,676	6,276	4,585	4,075
Long-Term Investments	1,469	1,451	1,508	1,001	1,502	599.43
Other Intangible Assets	1,165	883.77	519.9	442.45	341.25	349.76
Long-Term Deferred Tax Assets	413.25	320.56	238.9	141.36	52.97	66.09
Long-Term Deferred Charges	3,721	2,829	2,052	569.38	197.63	155.09
Other Long-Term Assets	423.23	383.3	442.55	648.99	-	-
Total Assets	48,338	43,785	42,371	39,266	34,730	27,556
Accounts Payable	1,540	1,334	1,493	1,920	1,151	1,289
Accrued Expenses	3.31	139.95	97.57	165.66	130.54	185.29
Short-Term Debt	-	-	1,261	-	-	-
Current Income Taxes Payable	356.04	59.28	4.03	21.77	25.14	17.75
Current Unearned Revenue	1,277	198.09	187.08	219.55	358.06	222.64
Other Current Liabilities	616.62	822.32	596.13	1,074	2,107	757.7
Total Current Liabilities	3,830	2,554	3,639	3,402	3,772	2,473
Long-Term Leases	51.3	75.18	98.86	151.59	-	-
Long-Term Unearned Revenue	42.55	38.95	119.44	116.52	141.24	122.22
Long-Term Deferred Tax Liabilities	83.16	83.64	100.45	24.77	29.76	24.09
Total Liabilities	4,007	2,751	3,958	3,694	3,943	2,619
Common Stock	6,379	6,379	6,379	6,396	5,332	4,423
Additional Paid-In Capital	3,222	3,058	3,020	3,356	3,143	1,663
Retained Earnings	35,447	32,102	28,819	25,928	23,530	19,103
Treasury Stock	-1,289	-1,092	-398.03	-664.94	-1,495	-419.84
Comprehensive Income & Other	7.82	19.32	3.23	-12.16	-4.79	6.53
Total Common Equity	43,768	40,466	37,824	35,003	30,504	24,775
Minority Interest	563.61	567.29	589.35	568.85	282.7	162.2
Shareholders' Equity	44,332	41,033	38,413	35,572	30,787	24,938
Total Liabilities & Equity	48,338	43,785	42,371	39,266	34,730	27,556
Total Debt	87.58	75.18	1,360	151.59	-	-
Net Cash (Debt)	22,818	20,770	16,511	18,570	16,433	13,563
Net Cash Growth	30.20%	25.79%	-11.08%	13.00%	21.15%	248.70%
Net Cash Per Share	3.60	3.28	2.58	2.91	2.57	2.12
Filing Date Shares Outstanding	6,274	6,361	6,367	6,382	6,355	6,342
Total Common Shares Outstanding	6,274	6,361	6,367	6,382	6,355	6,342
Working Capital	30,627	28,734	27,295	26,786	24,278	19,839
Book Value Per Share	6.98	6.36	5.94	5.48	4.80	3.91
Tangible Book Value	42,603	39,582	37,304	34,561	30,163	24,426
Tangible Book Value Per Share	6.79	6.22	5.86	5.42	4.75	3.85
Buildings	-	3,854	3,541	2,700	2,141	1,720
Machinery	-	5,969	5,684	5,120	4,063	3,395
Construction In Progress	-	1,101	1,193	1,659	1,305	1,533

Source: S&P Capital IQ. Standard template. Financial Sources.